CFO & CBO · Dianthus Therapeutics, Inc. /DE/ · Common Stock
Side
M
Value
$169K
Shares
20.0K
Price
$8.44
Executed
Dec 4, 2025
Disclosed
Dec 5, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Dec 4 executedDec 5, 2025 disclosed
DNTH · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+4 / 25
$169K reported value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Savitz Ryan filed this Form 4 reporting a option exercise of DNTH on Dec 4, 2025. It became public on Dec 5, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CFO & CBO
Savitz Ryancik:0001992324
Issuer
Dianthus Therapeutics, Inc. /DE/cik:0001690585
Revision history · 0
No field has changed since this record was first ingested.
